Reuters logo
BRIEF-Shandong Buchang Pharmaceuticals unit receives approval for drug clinical trials
June 21, 2017 / 5:50 AM / 3 months ago

BRIEF-Shandong Buchang Pharmaceuticals unit receives approval for drug clinical trials

June 21(Reuters) - Shandong Buchang Pharmaceuticals Co Ltd :

* Says its unit has been granted approval for drug clinical trials for BC0335 APIs and BC0335 granules issued by china food and drug administration

* BC0335 is used for treatment of respiratory syncytial virus (RSV) infection in children

Source text in Chinese: goo.gl/MkoiX7

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below